XR iPSC-Derived Vascularized Lung Organoid Differentiation Kit

Description

Generating reproducible human brain organoids can be difficult when embryoid bodies form unevenly, neural induction varies between experiments, or developing organoids do not receive the appropriate medium at each stage. These workflow variables can affect organoid morphology, neural lineage development, and the consistency of downstream brain development studies.

XR Cerebral Organoid Differentiation Kit is a chemically defined, stage-specific culture system designed to differentiate human pluripotent stem cells (hPSCs), including induced pluripotent stem cells (iPSCs), into three-dimensional cerebral organoids. The workflow guides cultures through embryoid body formation, neural induction, neural expansion, matrix embedding, and orbital maturation using four dedicated media.

The resulting hPSC-derived cerebral organoids are described as large, optically dense structures containing multiple lineage characteristics and cortical-like regions. By organizing the differentiation process into clearly defined stages from Day 0 through Day 40 and beyond, the kit provides researchers with a structured brain organoid culture workflow for studying early human neural and cortical development.

This cerebral organoid culture kit supplies sufficient medium to generate approximately 48 cerebral organoids under the described culture format. It is intended for research applications involving human brain organoid formation, neural tissue development, three-dimensional brain models, and long-term organoid culture.

Specifications

Kit Components

Features

• Four-stage cerebral organoid differentiation workflow covering embryoid body formation, neural induction, neural expansion, and organoid maturation

• Chemically defined culture system developed for human pluripotent stem cell differentiation

• Compatible with human iPSC-based cerebral organoid culture workflows

• Stage-specific media help simplify medium selection throughout the differentiation timeline

• Supports the formation of large, optically dense cerebral organoids with multiple cortical-like regions

• Includes sufficient medium for approximately 48 cerebral organoids under the described culture format

• Supports continued orbital culture beyond Day 40 for organoid growth to the desired experimental size

• Suitable for three-dimensional human neural development and cerebral tissue modeling research

Four-Stage Differentiation Workflow

The cerebral organoid differentiation protocol uses four sequential culture stages. Each medium is assigned to a defined developmental window to support the transition from undifferentiated human iPSCs to developing three-dimensional cerebral organoids.

Day 0–6: Embryoid Body Formation

Begin differentiation when the iPSC culture reaches approximately 80% confluency. On Day 0, dissociate the cells into a single-cell suspension and seed them into a 96-well low-attachment U-bottom plate using Cerebral Organoid Induction Medium A. Maintain the cultures through Day 6 and replace the medium every other day.

Day 7–10: Neural Induction

On Day 7, transfer the developing organoids to a 24-well low-attachment plate and replace the culture medium with Cerebral Organoid Induction Medium B. Maintain the organoids under static culture conditions and replace the medium every other day through Day 10.

Day 11–13: Matrix Embedding and Neural Expansion

From Day 11, embed the developing organoids in an appropriate extracellular matrix material and return them to a 24-well low-attachment plate. Culture the embedded organoids in Cerebral Organoid Induction Medium C under static conditions, replacing the medium every other day.

Day 14–40+: Orbital Culture and Organoid Maturation

From Day 14, place the 24-well low-attachment plate on an orbital shaker operating at 65–75 rpm. Replace the culture medium with Cerebral Organoid Induction Medium D and continue changing the medium every other day. Cultures may be maintained beyond Day 40 until the cerebral organoids reach the size required for the planned research application.

Performance Data

Cerebral Organoid Morphology During Differentiation

The documented culture workflow shows progressive morphological changes from adherent iPSC culture to compact embryoid body formation, neural induction, neural tissue expansion, and the development of a larger cerebral organoid by Day 40 and beyond. Matrix embedding is introduced during the neural expansion stage before orbital maturation culture.

Neural and Cortical Marker Expression

Immunofluorescence data from the differentiated cerebral organoids include staining for TUJ, PAX6, CTIP2, and FOXG1. Together, these markers provide evidence of neural differentiation, neural progenitor development, cortical neuronal identity, and forebrain-associated tissue characteristics within the organoid cultures.

Applications

XR Cerebral Organoid Differentiation Kit is intended for researchers requiring a structured method for generating hPSC-derived cerebral organoids. The resulting three-dimensional neural tissue models may support studies that require human-relevant developmental context beyond conventional two-dimensional neural cell culture.

Human Brain Development Research

Human cerebral organoids provide a three-dimensional model for investigating early neural development, tissue organization, and the emergence of cortical-like regions. The staged workflow can be used in research examining the transition from pluripotent stem cells through embryoid body formation, neuroectoderm induction, neural progenitor expansion, and cerebral tissue maturation.

Cortical and Forebrain Development Studies

The presence of PAX6-, CTIP2-, and FOXG1-associated signals makes these organoids relevant to studies of neural progenitor development, cortical neuronal differentiation, and forebrain-related tissue specification. Researchers may use the system to investigate developmental pathways involved in human cortical and telencephalic organization.

Human iPSC Disease Modeling

Patient-derived or genetically modified iPSC lines may be differentiated into cerebral organoids for comparative research on neurodevelopmental phenotypes. Experimental design should include suitable controls and independent validation because differentiation behavior may vary between iPSC lines.

Gene Editing and Functional Studies

Gene-edited human pluripotent stem cell lines can be incorporated into cerebral organoid workflows to study how selected genetic changes influence neural induction, organoid morphology, marker expression, and three-dimensional tissue development.

Drug Discovery and Compound Evaluation

Human brain organoid models may provide a research platform for preliminary compound evaluation, phenotype-based screening, and studies of developmental responses in three-dimensional neural tissue. Assay suitability, dosing conditions, endpoint selection, and organoid-to-organoid variability should be validated for each screening workflow.

Neurotoxicity Research

Developing cerebral organoids may be used in research investigating how test compounds influence neural differentiation, tissue morphology, cell viability, or developmental marker expression. This product is intended for research use and is not a validated clinical or diagnostic testing system.

Long-Term Neural Organoid Culture

The Day 40+ maturation stage supports continued orbital culture until the organoids reach the size required for the study. This makes the workflow applicable to research requiring extended cerebral organoid culture and later-stage analysis of neural tissue development.

• Human cerebral organoid generation from iPSCs and other hPSCs

• Early human brain development research

• Cortical development and forebrain specification studies

• Neural induction and neural progenitor differentiation research

• Three-dimensional human neural tissue modeling

• Human iPSC-based neurodevelopmental disease modeling

• Gene editing and isogenic cell line comparison studies

• Phenotype-based drug discovery and compound screening research

• Developmental neurotoxicity research

• Long-term cerebral organoid culture and maturation studies

Why Use a Stage-Specific Cerebral Organoid Kit?

Cerebral organoid formation requires different culture conditions as cells move from pluripotency toward embryoid body formation, neural induction, tissue expansion, and maturation. Using one general medium throughout the process may not provide the changing developmental signals required at each stage.

XR Cerebral Organoid Differentiation Kit separates the workflow into four dedicated media, helping laboratories organize critical medium transitions and maintain a consistent differentiation schedule. The combination of low-attachment culture, matrix embedding, and orbital maturation provides a complete workflow from human iPSC culture to Day 40+ cerebral organoid formation.

For laboratories establishing a human brain organoid model, this defined stage structure can simplify experimental planning, reduce the need to prepare multiple differentiation formulations independently, and provide a common workflow for comparing organoid outcomes across experiments.

Culture Considerations

• Begin with healthy, undifferentiated human pluripotent stem cell cultures at approximately 80% confluency.

• Generate a uniform single-cell suspension before seeding the 96-well low-attachment plate.

• Maintain consistent seeding conditions to reduce variation in embryoid body size.

• Follow the specified medium transition schedule for each differentiation stage.

• Handle developing organoids carefully during transfer and matrix embedding.

• Maintain the orbital shaker between 65 and 75 rpm during the maturation stage.

• Evaluate each hPSC line independently because organoid formation efficiency and morphology may vary by cell line.

• Use appropriate morphological, molecular, and immunostaining endpoints to validate organoid identity for the intended application.

FAQ

For Research Use Only. Not intended for diagnostic, therapeutic, or clinical applications.